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Yunqing Shi, Svetlana Katsev, Chenleng Cai, and Sylvia Evans1
Department of Medicine, University of California at San Diego, La Jolla, California 92093-0613
In these studies, we have taken advantage of a transient transgenic strategy in Xenopus embryos to demonstrate that BMP
ignaling is required in vivo for heart formation in vertebrates. Ectopic expression of dominant negative Type I (tALK3) or
ype II (tBMPRII) BMP receptors in developing Xenopus embryos results in reduction or absence of heart formation.
dditionally, blocking BMP signaling in this manner downregulates expression of XNkx2-5, a homeobox gene required for
ardiac specification, prior to differentiation. Notably, however, initial expression of XNkx2-5 is not affected. Mutant
henotypes can be rescued by co-injection of mutant with wild-type receptors or co-injection of mutant receptors with
Smad1, a downstream mediator of BMP signaling. Whole-mount in situ analyses indicate that ALK3 and XSmad1 are
oexpressed in cardiogenic regions. Together, our results demonstrate that BMP signaling is required for maintenance of
Nkx2-5 expression and heart formation and suggest that ALK3, BMPRII, and XSmad1 may mediate this
ignaling. © 2000 Academic Press
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(INTRODUCTION
Experiments performed in vitro in chick explants suggest
that bone morphogenetic protein (BMP) signaling may be
required for cardiac specification and heart formation dur-
ing late gastrulation or early neurula stages (Lough et al.,
1996; Schultheiss et al., 1997). In vertebrates, mRNAs
encoding BMPs are expressed in cardiogenic regions during
embryogenesis (Hemmati-Brivanlou and Thomsen, 1995;
Schultheiss et al., 1997). However, direct in vivo evidence
for the requirement of BMP signaling in vertebrate heart
formation has been lacking. Accordingly, we initiated stud-
ies in developing Xenopus embryos to examine the require-
ment for BMP signaling in cardiac specification and heart
formation.
BMPs are members of the transforming growth factor b
(TGF-b) superfamily. TGF-b family ligands bind to het-
rodimeric receptors comprising Type I and Type II serine–
hreonine kinase receptors. Ligand binding induces
ransphosphorylation of Type I receptors by constitutively
ctive Type II receptors. The activated Type I receptor then
hosphorylates an interacting effector Smad, which het-
1 To whom correspondence should be addressed. Fax: (858) 534-
8081. E-mail: syevans@ucsd.edu.
226rodimerizes with a co-Smad (Smad4) and is translocated to
he nucleus. This Smad complex can then bind either
ndependently or in concert with other transcription factors
o effect gene transcription. The specificity of this response
s thought to be mediated by selective ligand binding by
pecific receptor complexes and selective interactions of
ype I receptors with effector Smads which then bind
pecific targets (Chen et al., 1998; Howell et al., 1999).
Currently, there are a number of BMP ligands (e.g., BMPs
, 4, 5, 7, 10; GDF5), four Type I receptors (ALK1, 2, 3, and
), three Type II receptors (BMPRII, ActRIIA, and ActRIIB),
hree effector Smads (Smad1, 5, and 8), two co-Smads
Smad4a and b), and two inhibitory Smads (Smad6 and 7)
which have been shown to be involved in BMP signaling
(Chen et al., 1998; LeSueur and Graff, 1999; Masuyama et
al., 1999).
A number of in vivo studies have been performed in mice
to ablate specific members of BMP signaling pathways. The
phenotypes of many of these knockouts are extremely early
embryonic lethal (BMP4, ALK3, ALK2, Smad 4), precluding
analyses of effects on heart development (Gu et al., 1999;
Mishina et al., 1995; Sirard et al., 1998; Winnier et al.,
1995). Other knockouts display a range of cardiac pheno-
types, including defects in critical left–right morphogenesis
of the heart (ActRIIb), abnormal placement and delayed
0012-1606/00 $35.00
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227BMP Signaling Required for Heart Formationfusion of cardiac primordia (BMP2 or Smad5), and defective
chamber maturation (septation, trabeculation, cushion for-
mation) (double knockout of BMP7 and BMP5) (Oh and Li,
1997; Solloway and Robertson, 1999; Yang et al., 1999;
Zhang and Bradley, 1996). Each of these is a critical aspect
of heart development. However, perhaps owing to early
lethality or genetic redundancy, the critical role of BMP
signaling in cardiac mesoderm specification and heart for-
mation has not been addressed by the mouse ablation
studies.
In the studies described here, we have utilized two
well-characterized dominant negative BMP receptors,
tALK3 and tBMPRII (Frisch and Wright, 1998; Suzuki et al.,
1994), to block BMP signaling in developing Xenopus em-
bryos. We have taken advantage of a transgenic strategy
recently developed in our laboratory which results in effi-
cient, relatively stable, yet mosaic expression of transgenes
following direct DNA injection into early embryos (Fu et
al., 1998a). This approach enables us to bypass the early
lethality and general effects on mesodermal induction of
blocking BMP signaling, allowing the detection of specific
effects on cardiogenesis. We earlier used the same approach
to demonstrate a requirement for tinman homologue action
during vertebrate cardiogenesis (Fu et al., 1998b).
MATERIALS AND METHODS
Plasmid DNAs for Microinjection
DNAs encoding tXALK3 (Suzuki et al., 1994), wild-type XALK3
(Graff et al., 1994), tXBMPRII, wild-type XBMPRII (Frisch and
Wright, 1998), and XMad1 (Graff et al., 1996) were subcloned into
a CS2 expression vector (Turner and Weintraub, 1994) which had
been modified by the addition of AAV-ITR sequences (Fu et al.,
1998a). The control CS2 n-bgal ITR plasmid has been described
previously (Fu et al., 1998a).
Embryo Microinjection
Xenopus laevis were purchased from Xenopus I and Nasco
companies. Ovulation was induced by injecting 300–500 U each of
human chorionic gonadotropin. Fertilized eggs were dejellied with
2% cysteine-HCl (pH 7.8) immediately following cortical rotation.
Plasmid DNAs were linearized prior to injection and injected with
5 mg/ml neutral tetramethylrhodamine dextran (MW 70,000) as a
ineage tracer (Cleaver et al., 1996) Embryos were injected into one
ell at the two-cell stage in 0.13 MMR solution containing 3%
icoll 400, and sodium penicillin and streptomycin sulfate, each at
0 mg/ml. After several cell cycles (about 3–4 h), the embryos were
ransferred to 0.13 MMR solution and maintained at 15°C. Devel-
pmental stages of injected embryos were determined by compari-
on to stages of uninjected control embryos (Nieuwkoop and Faber,
967). Only morphologically normal embryos were scored, and
ach experiment was performed a minimum of three times.
DNAs for the dominant negative receptor and control constructs
ere linearized prior to injection.
Copyright © 2000 by Academic Press. All rightWhole-Mount in Situ Hybridization and Histology
Riboprobes were prepared by in vitro transcription of linearized
DNA templates in the presence of digoxigenin-11–UTP (Boehringer
Mannheim). The cDNA plasmid encoding XMLC2 has been de-
scribed previously (Evans et al., 1995) and was linearized with
BamHI and transcribed with T7 RNA polymerase to generate an
antisense riboprobe. The cDNA plasmid encoding XcTnI was
obtained by a PCR containing degenerate oligonucleotide primers
complementary to conserved regions of chick and mouse cTnI and
cDNA from adult Xenopus heart. The resulting cDNA cloned into
vector pCRII encoded sequences in agreement with those reported
for XcTnI (Drysdale et al., 1994). pCRcTnI was linearized with
EcoRI and transcribed with T7 RNA polymerase to generate an
antisense riboprobe for XcTnI. Riboprobes for XNkx2-5 were ob-
tained by linearizing plasmid XCsx2 (courtesy of Seigo Izumo) with
XbaI and transcribing with T7 RNA polymerase. Probes were
purified by an RNase-free Chroma Spin-100 column (Clontech)
prior to use and were not hydrolyzed.
Embryos were fixed and processed as described (Harland, 1991),
being stained with BCIP/NBT. The staining reaction was allowed
to proceed from 2 h to overnight. Stained embryos were fixed and
dehydrated prior to photographing.
Some specimens were sectioned after staining and were fixed 1–2
h, dehydrated in ethanol, permeabilized briefly in Histoclear fol-
lowed by 2 3 20 min changes in 1:1 xylene:paraffin wax at 60°C,
and embedded in paraffin wax. Sections (10 mm) were cut, dried,
dewaxed by passing through Histoclear 2 3 10 min, mounted in
ermount, and photographed.
RESULTS
Ectopic Expression of Dominant Negative BMP
Receptors Adversely Affects the Expression of
Differentiated Cardiac Markers and Results in
Absence of Morphologically Recognizable Heart
To examine the requirement for BMP signaling in cardiac
specification, our strategy was to ectopically express domi-
TABLE 1
Differentiated Cardiac Phenotype of Embryos Injected
with Dominant Negative BMP Receptors
DNA Amt inj (pg) No. scored Mutant (%) P valuea
CS2nb-gal 200 60 2 (3.0)
tALK3 200 112 29 (26) 0.0039*
BMPRII 200 143 38 (27) 0.0024*
Note. Injections were performed into one cell at the two-cell
tage, and embryos were harvested postcardiac differentiation at
tages 28–42 and examined by whole-mount in situ analyses for
xpression of XMLC2 or XcTnI. Embryos which exhibited asym-
etric reduction (20% or more) or absent staining for either of the
wo differentiation markers, or with clearly abnormal cardiac
orphology (see Fig. 1 for examples), were scored as mutant.
a P values were generated by x2 analyses and refer to the null
ypothesis that experimental and control embryos are equivalent.
* The null hypothesis is rejected at a significance level of 0.01.nant negative BMP receptors by injecting DNA plasmids
s of reproduction in any form reserved.
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229BMP Signaling Required for Heart Formationencoding the receptor into Xenopus embryos. Control in-
jections were performed with b-galactosidase expression
ectors. To improve the efficiency of transgene expression,
xpression cassettes within each vector were bracketed by
ne copy of the inverted terminal repeat sequences (ITRs)
rom adeno-associated virus (AAV) (Fu et al., 1998a).
The dominant negative BMP receptors which we utilized
ere well-characterized C-terminal truncations of the cy-
oplasmic domain (Frisch and Wright, 1998; Graff et al.,
994; Suzuki et al., 1994). Truncated receptors retain the
bility to heterodimerize with wild-type partners, yet are
nable to trigger a signaling cascade. Both Type I and Type
I dominant negative BMP receptors have previously been
sed to block BMP signaling in Xenopus embryos.
In Drosophila, loss-of-function mutants of a Dpp recep-
or, thickveins (tkv), exhibit no dorsal vessel formation
Frasch, 1999). Tkv is a Type I serine/threonine kinase
eceptor and XALK3 is the Xenopus homologue of Tkv.
herefore, we thought it important to explore the effect of
xpressing truncated XALK3 (tXALK3) on heart formation
n Xenopus embryos. However, evidence that Type I BMP
eceptors can interact with either BMP Type II or activin
ype II receptors (Liu et al., 1995; Rosenzweig et al., 1995)
aises the question as to the specificity of Type I dominant
egative receptors. In addition, a truncated Type II receptor
XActRIIb) has been shown to block both activin and BMP
ignaling in vivo (Chang et al., 1997). Recently, a BMP Type
I receptor, BMPRII, has been cloned from Xenopus. Previ-
us results in mammals identified BMPRII as the only Type
I receptor which exclusively bound BMPs, but not activins
r TGFbs (Liu et al., 1995; Rosenzweig et al., 1995).
onsistent with this observation, dominant negative XBM-
RII (tXBMPRII) was demonstrated to selectively block
MP, but not activin, signaling in Xenopus embryos (Frisch
and Wright, 1998). Moreover, XBMPRII mRNA is expressed
in cardiogenic regions (Frisch and Wright, 1998). Conse-
quently, to ensure that we were specifically blocking BMP
signaling with our dominant negative receptors, we per-
FIG. 1. Whole-mount RNA in situ analysis of heart differentia
constructs. Embryos were injected into one cell at the two-cell s
postdifferentiation (St. 27/28), and stained for expression of mRNAs
In each series, the leftmost embryo is a control injected with CS2n
DNAs encoding tBMPRs, note abnormal fusion and reduced or abs
exhibit distinctly abnormal heart morphology. Embryos shown wer
in A, 5 and B, 5, which were stained for XcTnI mRNA. Compara
arrows indicate asymmetric staining. (A) St. 29/30: (1) CS2n-bgal in
ALK3 injected. (B) St. 31/32: (1) CS2n-bgal injected, (2) tBMPRII in
33/35: (1) CS2n-bgal injected, (2) tBMPRII injected, (3) tALK3 injec
injected, (4) tALK3 injected.
FIG. 2. Section analyses of embryos stained by whole-mount in si
5 embryos shown in Fig. 1C. (A) Control-injected embryo, show
bnormal cardiac development, with rather than a single uniform h
eart tissue and absence of a lumen (green arrowhead). (C) tALK3reveals partially fused heart tubes. E, endocardium; Mi, midgut; My, m
Copyright © 2000 by Academic Press. All rightformed injections with DNAs encoding tXBMPRII as well
as tALK3.
Following injection into one cell at the two-cell stage,
embryos were allowed to develop and subsequently scored
by whole-mount in situ hybridization for the expression of
TABLE 2
Rescue of tBMPR Mutant Phenotypes by Co-injection
with Wild-Type BMPRs and XSmad1
DNA
Amt inj
(pg)
No.
scored
Mutant
(%) P valuea
CS2n-bgal 200 60 2 (3.0)
CS2n-bgal 400 172 15 (8.8)
CS2n-bgal 500 212 20 (9.4)
tALK3 200 22 7 (32) 0.0156*
tALK3 1 wtALK3 200 1 200 31 5 (16) 0.3973
tALK3 1 wtALK3 200 1 300 27 3 (11) 0.8469
tBMPRII 200 143 38 (27) 0.0024**
tBMPRII 1 wtBMPRII 200 1 200 68 14 (21) 0.0850
tBMPRII 1 wtBMPRII 200 1 300 88 5 (5.7) 0.4334
tALK3 200 112 29 (26) 0.0039**
tALK3 1 XSmad1 200 1 200 74 10 (14) 0.4305
tALK3 1 XSmad1 200 1 300 75 7 (9.0) 0.9870
Note. Rescue experiments were performed by co-injection of
dominant negative receptors and the wild-type constructs indi-
cated, into one cell at the two-cell stage. Embryos were harvested
at stages postdifferentiation and scored for the presence of mutant
phenotypes by whole-mount in situ analyses for XMLC2. Increas-
ing the amount of co-injected wild-type results in a corresponding
decrease in observed mutant phenotypes, indicating that the ob-
served phenotypes do not result from a nonspecific effect of DNA
injection on cardiogenesis.
a P values were generated by x2 analyses and refer to the null
ypothesis that experimental and control embryos are equivalent.
* The null hypothesis is rejected at a significance level of 0.05.
** The null hypothesis is rejected at a significance level of 0.01.
markers following injection of dominant negative BMP receptor
with CS2n-bgal, tBMPRII, or tALK3, harvested at various stages
ding XMLC2 or XcTnI. Embryos shown are anterior ventral views.
, illustrating normal heart development. In embryos injected with
taining on one side of the embryo. Later stage embryos (C and D)
ined for XMLC2 mRNA, with the exception of the embryos shown
sults were obtained with either marker. C, cement gland. White
ed, (2) tBMPRII injected, (3) tALK3 injected, (4) tALK3 injected, (5)
d, (3) tALK3 injected, (4) tALK3 injected, (5) tALK3 injected. (C) St.
D) St. 38: (1) CS2n-bgal injected, (2) tBMPRII injected, (3) tBMPRII
r expression of XMLC2 mRNA. Sections shown are from the stage
normal heart formation. (B) tBMPRII-injected embryo, exhibiting
tube, a bipartite structure, in which one side exhibits both reduced
cted embryo, in which staining for expression of XMLC2 mRNAtion
tage
enco
-bgal
ent s
e sta
ble re
ject
jecte
ted. (
tu fo
ing
eart
-injeyocardium; N, notochord; NT, neural tube; O, otic vesicle.
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230 Shi et al.genes which are specifically expressed in differentiated
heart, XMLC2 or XcTnI (Drysdale et al., 1994; Logan and
ohun, 1993). For each dominant negative receptor, we
erformed preliminary studies injecting from 100 to 400 pg
f DNA to determine the dose of receptor which would give
s a significant frequency of mutant phenotypes with the
xperimental cDNA constructs, but relatively low fre-
uency of abnormal phenotypes with control b-galactosi-
ase injections. We found that 200 pg appeared to be an
ptimal dose for either dominant negative receptor, and
ost of our experiments were performed utilizing this dose,
nless otherwise indicated.
Cardiac mutant phenotypes were scored in embryos
hich appeared relatively normal phenotypically. In this
anner we examined the relatively specific effects of block-
ng BMP signaling on cardiogenesis. Grossly abnormal
mbryos were not scored. Injection of AAV-ITR DNA
lasmids into Xenopus embryos results in a distribution of
mbryos exhibiting varying amounts of transgene expres-
ion, in which some embryos express the transgene in
irtually all descendants of the injected cell and others
TABLE 3
Asymmetric XNkx2-5 Expression in Xenopus Embryos Injected w
DNA pg
St. 14–20
No. scored Mut (%)a
CS2nb-gal 200 119 2 (2.0)
tALK3 200 104 2 (2.0)
tBMPRII 200 101 1 (1.0)
Note. Embryos were injected with either dominant negative BM
through 30, and scored for the expression of XNkx2-5 by whole-m
a Mut, mutant. Embryos which exhibited asymmetric reduct
utant.
b P values were generated by x2 analyses and refer to the null
* The null hypothesis is rejected at a significance level of 0.05
** The null hypothesis is rejected at a significance level of 0.01
FIG. 3. Whole-mount RNA in situ analysis of XNkx2-5 expressi
Embryos were injected into one cell at the two-cell stage with CS
tained for expression of XNkx2-5 mRNA. Embryos in A are anter
he leftmost embryo is a control injected with CS2n-bgal, illustratin
mbryos harvested from stages 14 through 20 exhibited norm
ater stages, however, exhibited asymmetric XNkx2-5 staining, a
mbryos shown were injected with DNA encoding tBMPRII. C
C) St. 25, (D) St. 28.
IG. 4. Section analyses of embryos stained by whole-mount in sit
where XNkx2-5 staining is reduced in response to ectopic exp
demonstrating XNkx2-5-positive staining in both cardiogenic meso
with tALK3, exhibiting downregulation of XNkx2-5 in both pha
(postdifferentiation) which was injected with tALK3, exhibiting
cardiogenic mesoderm; NT, neural tube; Mi, midgut; N, notochord; PE
Copyright © 2000 by Academic Press. All rightxpress in subsets of the descendants (Fu et al., 1998a). In
he case of the dominant negative receptor injections, it is
ikely that the grossly abnormal embryos were those in
hich the transgene was expressed early on in a large
ercentage of the descendents of the injected cell. Numer-
us studies have shown that BMP signaling is critical for
arly mesodermal patterning in Xenopus (Dale and Jones,
999). In mice, ablation of several members of the BMP
ignaling pathway (BMP4, ALK3, ALK2, Smad 4) results in
arly embryonic lethality, confirming an early requirement
or BMP signaling in order for normal development to
roceed (Gu et al., 1999; Mishina et al., 1995; Sirard et al.,
998; Winnier et al., 1995).
Our results with injection of constructs encoding either
ALK3 or tBMPRII were comparable. Injection of either
eceptor construct resulted in a statistically significantly
ncreased frequency (26–27%) of mutant hearts relative to
ontrol embryos injected with the b-galactosidase expres-
ion vector (3.0%) (Table 1). Similar phenotypes were ob-
erved upon injection with either truncated BMP receptor
nd with scoring for either XMLC2 or XcTnI expression.
MPRs
St. 21–30
P valueb No. scored Mut (%) P value
81 4 (5.0)
0.3234 79 16 (20) 0.0330*
0.7573 150 34 (23) 0.0079**
ceptor into one cell of the two-cell stage, harvested at stages 14
in situ analyses.
0% or more) in staining for XNkx2-5 expression were scored as
thesis that experimental and control embryos are equivalent.
llowing injection of dominant negative BMP receptor constructs.
gal, tBMPRII, or tALK3 harvested from stages 14 through 30, and
iews. The remaining images show anterior ventral views. In each,
rmal XNkx2-5 expression. Following injection with either tBMPR,
kx2-5 expression, as represented in A and B. Embryos from
h pre- and postdifferentiation stages, as represented in C and D.
rable results were obtained with tALK3. (A) St. 15, (B) St. 19,
expression of XNkx2-5 mRNA. Green arrowheads indicate regions
on of tBMPRs. (A) Control St. 25 (predifferentiation) embryo,
and pharyngeal endoderm. (B) St. 25 embryo which was injected
eal endoderm and cardiogenic mesoderm. (C) St. 29/30 embryo
metric downregulation of XNkx2-5 in cardiac mesoderm. CM,ith tB
P re
ount
ion (2
hypo
.on fo
2n-b
ior v
g no
al XN
t bot
ompa
u for
ressi
derm
ryng
asym, pharyngeal endoderm.
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232 Shi et al.Consequently, the summarized data represent embryos
scored for either marker of cardiac differentiation. Results
following co-injection of both dominant negative receptors
were comparable to those obtained with each alone, sug-
gesting that the two tBMPRs are blocking the same path-
way (data not shown).
A range of mutant phenotypes was observed. Embryos
scored as mutant were those in which MLC2 or cTnI
taining was asymmetric, either reduced or absent on one
ide (reflecting the asymmetric injection of the dominant
egative receptor construct into one cell at the two-cell
tage), or which exhibited delayed or abnormal fusion of
ardiac primordia (Fig. 1). Notably, some embryos exhibited
omplete absence of expression of differentiated markers on
ne side. Embryos of later stages, when the heart has fully
ooped, were scored as mutant if hearts exhibited clearly
bnormal morphology (Fig. 1D).
Section analysis was performed for some embryos follow-
ng whole-mount RNA in situ, as shown by representative
sections in Fig, 2. Examination of sections confirmed the
impressions from whole-mount staining, demonstrating
greatly reduced or absent cardiac mesoderm on one side
(Fig. 2B) and incomplete fusion of heart tubes (Fig. 2C). As
can be seen from Fig. 2B, the reduction in staining for
XMLC2 mRNA reflects a reduction in cardiac mesoderm
per se.
Rescue of Cardiac Mutant Phenotypes by Co-
injection of Dominant Negative Receptors with
Their Wild-Type Counterparts or XSmad1
To confirm the specificity of action of the dominant
negative receptors, rescue experiments were performed by
co-injecting 200 pg of cDNA encoding a truncated receptor
with 200 or 300 pg of its wild-type counterpart. Control
injections were performed by injection of 400 or 500 pg of
the b-galactosidase expression plasmid. As can be seen from
Table 2, results of these experiments demonstrated that
inclusion of wild-type receptor rescued the mutant pheno-
types, in a dose-responsive manner. Co-injection of 200 pg
of tBMPR plasmid and either 200 or 300 pg of the corre-
sponding wild-type receptor plasmid resulted in a frequency
of mutant phenotypes which was not significantly different
from that observed in control injected embryos (see P
alues, Table 2).
Smads are downstream mediators of TGFb family signal-
ing, and Smads 1, 5, and 8 are considered specific for BMP
signaling (Chen et al., 1998). As an additional test of the
specificity of action of tALK3, we performed rescue experi-
ments co-injecting expression constructs for tALK3 and
XSmad1. As for the wild-type receptor, expression of XS-
mad1 resulted in a dose-dependent rescue of the mutant
cardiac phenotypes (Table 2), reinforcing the idea that the
observed phenotypes were a result of blocking BMP signal-
ing pathways.
Copyright © 2000 by Academic Press. All rightExpression of Truncated BMP Receptors Results in
the Downregulation of a Marker for Cardiogenic
Mesoderm, XNkx2-5
To determine whether blocking BMP signaling affected
earlier stages of cardiac mesoderm specification than exam-
ined by scoring for expression of differentiated markers, we
harvested embryos from stages 14–30 following injection
with either tALK3 or tBMPRII and scored for expression of
XNkx2-5 mRNA. XNkx2-5 mRNA is first detectable by in
situ hybridization at midgastrulation (approximately stage
14), when it is expressed in both cardiogenic mesoderm and
pharyngeal endoderm (Tonissen et al., 1994). Previous stud-
ies have demonstrated that XNkx2-5 is required for cardiac
specification and heart formation (Fu et al., 1998b; Grow
and Krieg, 1998).
Results of our analysis of XNkx2-5 expression in injected
embryos are summarized in Table 3. We were unable to
observe any effects of ectopic expression of the dominant
negative BMPRs on XNkx2-5 expression in embryos from
stages 14–20. However, at later stages (21–30), we observed
a statistically significant increase in the number of embryos
exhibiting asymmetric staining for XNkx2-5: 20–23% ver-
sus 5% in control embryos (Table 3). Embryos stained for
XNkx2-5 mRNA and representative of observed phenotypes
are shown in Fig. 3, including earlier stages with no appar-
ent alteration in XNkx2-5 staining following injection of
tBMPR constructs (Figs. 3A and 3B) and later predifferenti-
ated (Fig. 3C) and postdifferentiated stages (Fig. 3D) which
exhibited asymmetric staining in response to ectopic ex-
pression of tBMPRs.
Section analysis of control and mutant embryos follow-
ing whole-mount RNA in situ analyses demonstrated that
XNkx2-5 expression was asymmetrically downregulated in
both pharyngeal endoderm and cardiogenic mesoderm, in
pre- and postdifferentiation embryos, as shown in Fig. 4.
ALK3 and Smad1 Are Expressed in Cardiogenic
Regions during Xenopus Development
Previous data have indicated that XBMPRII mRNA is
expressed in cardiogenic regions during Xenopus develop-
ment (Frisch and Wright, 1998). However, there are no
published data on the expression of ALK3 mRNA during
Xenopus development. Some data have been published on
the expression of XSmad1 (Meersseman et al., 1997; Thom-
en, 1996); however, cardiogenic regions were not exam-
ned. Therefore, to investigate whether ALK3 or Smad1 is
expressed in a manner consistent with their being involved
in cardiogenesis, we performed whole-mount in situ analy-
sis on embryos of various stages. Results of this analysis are
shown in Fig. 5.
Strong staining for ALK3 mRNA (Figs. 5A–5D) was ob-
served in otic vesicle, in eye, in dorsoanterior neural tube,
and in pharyngeal structures. Lower levels of staining were
observed in anterior ventral and posterior ventral regions of
the embryo and along the entire dorsolateral region. This
staining was not observed with a sense control probe,
s of reproduction in any form reserved.
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233BMP Signaling Required for Heart Formationdemonstrating its specificity (data not shown). The staining
in anterior ventral regions overlaps with cardiogenic re-
gions (indicated by arrowheads), suggesting that low levels
of receptor are expressed in cardiogenic regions at all stages
examined. The ALK3 mRNA expression pattern overlaps,
ut is distinct from, that previously observed for BMP4
Fainsod et al., 1994). BMP4 mRNA is strongly expressed in
tic vesicle, eye, pharyngeal regions, and posterior and
nterior ventral regions, the latter including cardiogenic
egions. In contrast to BMP4, however, ALK3 is not ex-
ressed in the midventral region (corresponding to the
entral blood islands).
Examination of XSmad1 expression revealed a generally
ore restricted, yet partially overlapping pattern of expres-
ion compared to that observed for XALK3 (Figs. 5E–5H). As
bserved previously, XSmad1 was highly expressed in otic
vesicle and cephalic neural crest (in migrating neural crest
and pharyngeal crest derivatives) (Thomsen, 1996). At early
stages (Figs. 5E and 5F), low levels of specific staining in
anterior ventral regions coincide with cardiogenic regions;
however, at later stages (Figs. 5Gand 5H), XSmad1 does not
appear to be expressed in cardiogenic regions.
DISCUSSION
BMP Signaling Is Required for Heart Formation
and Expression of Differentiated Markers and
Complete Fusion of Heart Primordia
Our results with whole-mount in situ analysis indicate
that ectopic expression of either dominant negative ALK3
or BMPRII resulted in a significant number of mutant
embryos with reduced or abrogated expression of two mark-
ers of the differentiated heart, XMLC2 and XcTnI (Table 1
and Fig. 1). Sectional analyses indicated that the reduced or
absent staining on the injected side reflected an absence of
morphologically recognizable heart (Fig. 2). Another fre-
quently observed mutant phenotype was incompletely
fused heart primordia. Embryos harvested at various stages
from the time of appearance of differentiated markers (stage
27/28) to a time when the heart is beating and looped (stage
38) revealed that blocking BMP signaling prevented normal
fusion at all stages (Fig. 1). This confirms results previously
observed in mouse embryos in which abnormal fusion of
heart primordia was observed in embryos null for either
BMP2 or Smad5 (Oh and Li, 1997; Zhang and Bradley,
996).
The cardiac mutant phenotypes we observed could be
escued in a dose-responsive manner by increasing amounts
f counterpart wild-type receptor, affirming that the pheno-
ypes were not arising from a nonspecific effect of DNA
njection (Table 2). In addition, rescue of mutant pheno-
ypes by XMad1, a downstream mediator of BMP signaling,
onfirmed that the dominant negative Type I receptor,
LK3, is specifically interfering with BMP signaling.
Copyright © 2000 by Academic Press. All rightTogether, our data prove that BMP signaling is required in
ivo for heart formation and expression of differentiated
arkers.
BMP Signaling Is Required to Maintain Nkx2-5
Expression Prior to Differentiation
XNkx2-5 has been shown to be required for cardiac
specification in Xenopus (Fu et al., 1998b; Grow and Krieg,
1998). The observed decrease or absence of heart tissue in a
significant proportion of mutant embryos following injec-
tion with dominant negative BMP receptors was reminis-
cent of phenotypes we had previously observed by injecting
a dominant negative XNkx2-5 construct into developing
embryos (Fu et al., 1998a). Accordingly, we examined
XNkx2-5 expression following ectopic expression of tALK3
or tBMPRII.
XNkx2-5 transcripts can be observed by RNase protection
in very early gastrula, but appear to be strongly upregulated
between stages 12 and 14 (Evans et al., 1995). By whole-
mount in situ analyses, XNkx2-5 transcripts are first readily
observed at stage 14 (late gastrula/early neurula). Early
XNkx2-5 expression occurs in both cardiogenic mesoderm
and adjacent endoderm (Cleaver et al., 1996; Evans et al.,
1995). Examination of XNkx2-5 expression in embryos
injected into one cell at the two-cell stage with tALK3 or
tBMPRII indicated that XNkx2-5 expression in embryos
from stages 14–20 was unaffected. Bilateral heart primordia
in anterior, lateroventral mesoderm at stage 15 begin to fuse
at the anterior midline between stages 16 and 19. This
fusion is accompanied by a ventralward migration so that
by stage 20, the single heart anlage is located ventrally,
caudal to the cement gland (Nieuwkoop, 1967). At these
stages, XNkx2-5 expression persists in both presumptive
cardiac mesoderm and juxtaposed presumptive pharyngeal
endoderm. Subsequently the XNkx2-5-positive endoderm
migrates anteriorward relative to the cardiogenic meso-
derm. Following the arrival of the heart primordium to its
final ventral location, ectopic expression of tALK3 or tBM-
PRII resulted in a reduction or absence of XNkx2-5 mRNA
on the injected side of the embryo (Fig. 3). This downregu-
lation of XNkx2-5 expression occurs prior to differentiation
and in differentiated heart and occurs in both pharyngeal
endoderm and cardiogenic mesoderm (Fig. 4). The fre-
quency of mutant phenotypes observed for XNkx2-5 expres-
sion (20–23%) was comparable to the frequency of mutant
phenotypes observed for the expression of differentiated
markers (26–27%), suggesting that downregulation of
XNkx2-5 expression is correlated with reduction or absence
of heart formation.
Our results suggest that initial XNkx2-5 expression is not
as sensitive to inhibition of BMP signaling following ec-
topic expression of tALK3 or tBMPRII as later, postgastrula
expression. In Drosophila during early gastrulation, tinman
is initially expressed throughout the mesoderm, then, post-
gastrulation, becomes restricted to dorsal mesoderm and is
subsequently selectively maintained in cardiac mesoderm
s of reproduction in any form reserved.
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235BMP Signaling Required for Heart Formation(Bodmer et al., 1990; Frasch, 1999). The early panmesoder-
mal expression is dependent on regulation by an E-box
transcription factor, Twist. However, restricted dorsal me-
sodermal expression is dependent on signaling by Decapen-
taplegic (Dpp), the Drosophila homologue of BMP. This
regulation occurs through a Dpp-responsive element in the
tinman promoter, which binds to Mad, Medea (homologues
of Smads), and Tinman itself (Frasch, 1999). Intriguingly,
the cardiac-specific element in the tinman promoter also
appears to be dependent on Dpp signaling (Rolf Bodmer,
personal communication), and the promoter element driv-
ing cardiac-specific expression contains essential CRE sites
that may serve as Dpp-response elements (Venkatesh et al.,
2000). Although the initially observed expression of
XNkx2-5 does not occur in a panmesodermal manner as for
tinman, our results suggest that initial expression of
XNkx2-5 during gastrulation, as with initial expression of
tinman, may be independent of BMP signaling, or at least
BMP signaling which is blocked by the tBMPRs we have
utilized in these studies.
In chick, cNkx2-5 expression is first observed in cardiac
primordia and adjacent endoderm at stage 5 (Schultheiss et
al., 1995), comparable to the time at which Xenopus
Nkx2-5 is first observed. Exposure of chick precardiac
mesendoderm to noggin, a BMP inhibitor, either by cultur-
ing explants in noggin-containing medium (Schultheiss et
al., 1995; Schlange et al., 2000) or by implantation of
noggin-expressing CHO cells in vivo (Schlange et al., 2000),
downregulates expression of cNkx2-5 and other cardiac
restricted genes and prevents heart development. This ef-
fect is observed when noggin is added between stages 4 and
8, but not following stage 8, suggesting that cardiac cells no
longer require BMP signaling by the latter stage. In these
experiments, embryos and explants were assayed 24–48 h
following noggin addition, therefore an early independence
of Nkx2-5 expression on BMP signaling, as seen in our
study, would not have been observed. In our experiments,
dominant negative BMP receptor expression is driven by
the CMV enhancer, which is expressed in Xenopus during
the earliest stages of gastrulation (Kroll and Amaya, 1995).
Our results provide the first evidence that maintenance, not
initiation, of Nkx2-5 expression is dependent on BMP
ignaling postgastrulation, at least in frog embryos.
FIG. 5. Whole-mount in situ analysis of ALK3 and Smad 1 mRN
ALK3 and Smad1 in cardiogenic regions during development, we pe
mRNAs was relatively weak, yet specific staining was observed.
compare to staining for XNkx2-5 as seen in Fig. 3). (A–D) Embry
expression of Smad1 mRNA. The staining patterns of the two gene
staining is observed in both anterior and posterior regions. This p
(Fainsod et al., 1994; Frisch and Wright, 1998). ALK3 is strongly exp
structures. Smad1, as previously published (Thomsen, 1996), is re
derivatives, neural tube, head, and eye. For A, B, E, and F, upper em
embryos are ventral views, oriented with anterior at the top. For C
at the top; lower embryos are ventral views, oriented with anterior
(D and H) St. 28/29.
Copyright © 2000 by Academic Press. All rightIn vitro experiments performed with chick embryo ex-
lants have suggested that at least two successive inductive
vents occur to specify cardiogenic mesoderm (Ladd et al.,
998). In the first, during early gastrulation (Hamilton
amburger (HH) stages 2–3), the hypoblast can induce
eating tissue in posterior epiblast (Yatskievych et al.,
997) and in a second event, at late gastrulation (HH stage
), anterior lateral endoderm (ALE) can induce the overlying
esoderm to activate cardiogenic markers and form beating
issue (Schultheiss et al., 1995; Sugi and Lough, 1995;
atskievych et al., 1997). The inducing activities of hypo-
last and ALE appear to be distinct. Activin can substitute
or the former activity, whereas a combination of BMP and
broblast growth factor can substitute for the latter. In
enopus embryos, a combination of explant and ablation
tudies suggests that two tissues are required for induction
f cardiogenic mesoderm during early gastrulation
Nieuwkoop–Faber stage 10): the dorsal organizer and deep
nterior endoderm (Nascone and Mercola, 1995; Sater and
acobson, 1990). Our results suggest that Xenopus cardiac
pecification, in a manner comparable to that seen in chick,
ay also involve a later, BMP-dependent event, to maintain
kx2-5 expression and perhaps expression of other cardiac-
pecification genes.
Expression of ALK3, BMPRII, and Smad1 mRNAs
Is Consistent with Their Mediating BMP Signaling
Which Is Required for Cardiogenesis
To investigate whether endogenous ALK3 is expressed at
the appropriate time and place to be mediating the observed
effects of its dominant negative mutant on cardiogenesis,
we performed whole-mount in situ analysis of ALK3
mRNA expression during Xenopus development. To the
best of our knowledge, these results represent the first
published study of XALK3 expression and indicate that
XALK3 is expressed at low levels in cardiogenic regions
(Fig. 5). In concert with our results following ectopic ex-
pression of tALK3, our data suggest that ALK3 is a candi-
date to be an endogenous mediator of BMP signals for
critical aspects of cardiogenesis, including specification and
heart formation. It is interesting to note that BMPRII
expression at early neurula stages is observed in posterior
pression during Xenopus development. To examine expression of
ed whole-mount RNA in situ analyses. Overall, expression of both
iogenic regions are indicated by black arrowheads (for reference,
ained for expression of ALK3 mRNA. (E–H) Embryos stained for
overlapping, but distinct. In stage 21/22 and early tailbud embryos,
rn overlaps with that previously observed for BMP4 and BMPRII
d in eye and is also expressed in neural tube, head, and pharyngeal
ely strongly expressed in migrating cephalic neural crest and its
are shown in anterior view, oriented with dorsal at the top; lower
G, and H, upper embryos are lateral views, oriented with anterior
e top. (A and E) St. 17/18, (B and F) St. 21/22, (C and G) St. 25/26,A ex
rform
Card
os st
s are
atte
resse
lativ
bryos
, D,
at ths of reproduction in any form reserved.
C
i
s
w
p
X
s
d
m
A
i
b
1
g
s
g
s
i
e
t
s
c
e
1
t
a
t
t
O
h
m
p
d
a
236 Shi et al.involuting mesoderm, but not in anterior, cardiogenic me-
soderm, yet at late neurula/early tailbud stages appears to
be strongly expressed in cardiogenic regions (Frisch and
Wright, 1998). The appearance of BMPRII mRNA in cardio-
genic regions coincides with the time at which we observe
a dependence of XNkx2-5 expression on BMP signaling,
suggesting that availability of BMPRII may regulate the
activation of BMP signaling to maintain Nkx2-5 expression.
o-injection of DNA encoding tALK3 and tBMPRII did not
ncrease the frequency of mutant phenotypes observed,
uggesting that both receptors are blocking the same path-
ay to result in the observed phenotypes.
To confirm that tALK3 was targeting BMP signaling, we
erformed rescue experiments with XSmad1. We found that
Smad1 could rescue the cardiac mutant phenotypes re-
ulting from ectopic expression of tALK3, in a dose-
ependent manner. Our results suggest that XSmad1 may
ediate heart formation downstream of BMP signaling.
ccordingly, we investigated whether XSmad1 is expressed
n cardiogenic regions. Although some in situ results have
een previously published for XSmad1 (Meersseman et al.,
997; Thomsen, 1996), no data were presented on cardio-
enic regions. Results of our whole-mount in situ analyses
uggest that XSmad1 is expressed at low levels in cardio-
enic regions, at earlier stages examined, but not at later
tages (Fig. 5). In concert with the rescue data, our data
ndicate that XSmad1 may be involved in critical aspects of
arly cardiogenesis. In this regard, it is interesting to note
hat recent studies in developing chick embryos demon-
trate that cSmad1 is expressed at low levels in early
ardiogenic regions between stages 6 and 7, and cSmad5 is
xpressed weakly in cardiac cells at stage 8 (Yamada et al.,
999).
Previous investigators have observed that individual
runcated ALK receptors can be specific in their mode of
ction. In particular, it has recently been demonstrated that
argeted ectopic expression of tALK2, but not tALK3 or
ALK4, can affect heart looping (Ramsdell and Yost, 1999).
ur results indicate that expression of tALK3 can affect
eart formation, expression of XNkx2-5 and differentiated
arkers, and fusion of heart primordia. Together with the
revious results on heart looping, our results suggest that
istinct BMP signaling pathways may mediate distinct
spects of heart formation.
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